Search

Author/Creator Binneman, Brendon

1. Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy. Issue 3 (10th May 2017)

Authors:
Landen, Jaren W.; Cohen, Sharon; Billing, Clare B.; Cronenberger, Carol; Styren, Scot; Burstein, Aaron H.; Sattler, Catherine; Lee, Jae‐Hong; Jack, Clifford R.; Kantarci, Kejal; Schwartz, Pamela F.; Duggan, William T.; Zhao, Qinying; Sprenger, Ken; Bednar, Martin M.; Binneman, Brendon
Journal:
Alzheimer's & dementia
Issue:
Volume 3:Issue 3(2017)
Page Start:
339
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1‐047: A Phase 2 Clinical Trial of PF‐05212377 (SAM‐760) in Subjects with Mild to Moderate Alzheimer's Disease with Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil. (1st July 2016)

Authors:
Fullerton, Terence; Binneman, Brendon; David, William; Delnomdedieu, Marielle; Kupiec, James; Lockwood, Peter; Mancuso, Jessica; Miceli, Jeffrey; Bell, Joanne
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 8
Page Start:
P419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ponezumab in mild‐to‐moderate Alzheimer's disease: Randomized phase II PET‐PIB study. Issue 3 (8th June 2017)

Authors:
Landen, Jaren W.; Andreasen, Niels; Cronenberger, Carol L.; Schwartz, Pamela F.; Börjesson‐Hanson, Anne; Östlund, Henrik; Sattler, Catherine A.; Binneman, Brendon; Bednar, Martin M.
Journal:
Alzheimer's & dementia
Issue:
Volume 3:Issue 3(2017)
Page Start:
393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search